3000x More Sensitive Than What Is On The Market – This Technology Moves The Needle

Lori Bisson, CEO of Autonomix Medical, Inc. AMIX, was recently interviewed by Benzinga.

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The company's first-in-class technology platform includes a catheter-based microchip sensing array that it says has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. 

Ms. Bisson spoke about the exciting opportunities that her company’s innovative technology presents.

Learn more here:

Featured photo by Robina Weermeijer on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.